2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial Valaciclovir, Placebo capsules (containing Avicel blend) - COPD, EBV | Phase 2 | Terminated | Belfast Health and Social Care Trust | 85 | 2018-10-11 | 2020-09-30 |
| Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma baltaleucel-T - Lymphoma, Extranodal NK-T-Cell, EBV | Phase 2 | Terminated | Cell Medica Ltd | 15 | 2014-09-01 | 2019-03-13 |
Epstein-Barr Virus Infections (1) · Lymphoma, Extranodal NK-T-Cell (1) · Pulmonary Disease, Chronic Obstructive (1)
Chronic Disease (1) · DNA Virus Infections (1) · Disease Attributes (1) · Herpesviridae Infections (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Valacyclovir (1)
Belfast Health and Social Care Trust (1) · Cell Medica Ltd (1)
United Kingdom (2) · France (1) · South Korea (1) · United States (1)
Helen Heslop, MD (1) · Joe Kidney, MB, MD (1) · Kurt Gunter, MD (1)